Variables | Virological failure | Unadjusted | Adjusted | |||
---|---|---|---|---|---|---|
No (n %) | Yes (n %) | OR (95%CI) | P-value | OR (95%CI) | P-value | |
Sex | ||||||
Male | 042 (24.28) | 09 (37.50) | ||||
Female | 131 (75.72) | 15 (62.50) | 1.9 (0.7–4.5) | 0.171 | ||
Age | ||||||
< 30 years | 012 (06.94) | 07 (29.17) | ||||
≥ 30 years | 161 (93.06) | 17 (70.83) | 5.5 (1.9–15.9) | 0.002 | 12.4 (2.7–56.1) | 0.001 |
Marital state | ||||||
Married | 46 (26.59) | 10 (41.67) | 1.9 (0.8–4.7) | 0.130 | – | – |
Divorced | 33 (19.08) | 03 (12.50) | 0.6 (0.2–2.2) | 0.439 | – | – |
Widow | 59 (34.30) | 05 (20.83) | 0.5 (0.3–1.4) | 0.194 | – | – |
Single | 34 (19.65) | 06 (25.00) | 1.3 (0.5–3.6) | 0.543 | – | – |
WHO stage at ART1 | ||||||
3&4 | 101 (58.38) | 13 (54.17) | ||||
1&2 | 072 (41.62) | 11 (45.83) | 0.8 (0.3–2.0) | 0.695 | – | – |
ART1months | ||||||
≤ 36 months | 015 (08.67) | 08 (33.33) | ||||
> 36 months | 158 (91.33) | 16 (66.67) | 5.3 (1.9–14.3) | 0.001 | 7.6 (1.9–29.0) | 0.003 |
CD4 at ART2 | ||||||
< 200cells/μl | 035 (20.23) | 18 (75.00) | ||||
≥ 200 cells/μl | 138 (79.77) | 06 (25.00) | 11.8 (4.3–32) | < 0.001 | 16.3 (5.-57.9) | < 0.001 |
WHO stage at ART2 | ||||||
3&4 | 121 (69.94) | 14 (58.33) | ||||
1&2 | 052 (30.06) | 10 (41.67) | 0.6 (0.3–1.4) | 0.255 | – | – |
ART2 months | 009 [05–11] | 6 [4.5–9.5] | 0.9 (0.7–1.0) | 0.065 | – | – |
Adherence < 95% | ||||||
Yes | 017 (09.83) | 08 (33.33) | ||||
No | 156 (90.17) | 16 (66.67) | 4.5 (2.3–12.3) | 0.002 | 3.4 (0.9–12.6) | 0.062 |
ART1rgm | ||||||
AZT/3TC/EFV | 32 (18.50) | 04 (16.67) | 0.9 (0.3–2.8) | 0.828 | – | – |
AZT/3TC/NVP | 66 (38.15) | 03 (12.50) | 0.2 (0.1–0.8) | 0.022 | – | – |
D4T/3TC/NVP | 15 (08.67) | 02 (08.33) | 0 .9 (0.2–4.4) | 0.956 | – | – |
TDF/3TC/EFV | 60 (34.68) | 15 (62.50) | 3.1 (2.1–7.6) | 0.011 | 0.5 (0.2–1.9) | 0.363 |
ART2rgm | ||||||
ABC/3TC/LPV.r | 86 (49.71) | 16 (66.67) | 2.1 (1.8–4.9) | 0.0125 | 2.1 (0.5–7.8) | 0.272 |
AZT/3TC/ATV.r | 07 (04.05) | 02 (08.33) | 2.1 (0.4–11.) | 0.357 | – | – |
AZT/3TC/LPV.r | 07 (04.05) | 02 (08.33) | 2.1 (0.4–11) | 0.357 | – | – |
TDF/FTC/ATV.r | 37 (21.39) | 01 (04.70) | 0.2 (0.2–1.2) | 0.077 | – | – |
TDF/FTC/LPV.r | 36 (20.81) | 03 (12.50) | 0.4 (0.2–1.9) | 0.346 | – | – |